參考文獻 |
1. Hu, B., et al., Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology, 2020: p. 1-14.
2. Helmy, Y.A., et al., The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. Journal of Clinical Medicine, 2020. 9(4): p. 1225.
3. Volz, E., et al., Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity. Cell, 2020.
4. Deng, S.-Q. and H.-J. Peng, Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. Journal of clinical medicine, 2020. 9(2): p. 575.
5. Cui, J., F. Li, and Z.-L. Shi, Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, 2019. 17(3): p. 181-192.
6. Ni, W., et al., Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Critical Care, 2020. 24(1): p. 1-10.
7. Zhou, P., et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature, 2020. 579(7798): p. 270-273.
8. Wrapp, D., et al., Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 2020. 367(6483): p. 1260-1263.
9. Li, W., et al., Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 2003. 426(6965): p. 450-454.
10. Xu, Z., et al., Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory medicine, 2020. 8(4): p. 420-422.
11. Savastano, A., et al., Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. Nature communications, 2020. 11(1): p. 1-10.
12. Zhang, X., et al., Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-κB. Virology, 2007. 365(2): p. 324-335.
13. Dutta, N.K., K. Mazumdar, and J.T. Gordy, The nucleocapsid protein of SARS–CoV-2: a target for vaccine development. Journal of virology, 2020. 94(13).
14. Fajgenbaum, D.C. and C.H. June, Cytokine storm. New England Journal of Medicine, 2020. 383(23): p. 2255-2273.
15. McGonagle, D., et al., Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome. Autoimmunity reviews, 2020: p. 102537.
16. Ragab, D., et al., The COVID-19 cytokine storm; what we know so far. Frontiers in immunology, 2020. 11: p. 1446.
17. Dzobo, K., et al., Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine. Omics: a journal of integrative biology, 2020.
18. Tang, Y., et al., Cytokine storm in COVID-19: the current evidence and treatment strategies. Frontiers in immunology, 2020. 11: p. 1708.
19. Chen, G., et al., Clinical and immunological features of severe and moderate coronavirus disease 2019. The Journal of clinical investigation, 2020. 130(5).
20. Qin, C., et al., Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical Infectious Diseases, 2020.
21. Tan, M., et al., Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. Immunology, 2020.
22. Huang, C., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 2020. 395(10223): p. 497-506.
23. Nasonov, E. and M. Samsonov, The role of Interleukin 6 inhibitors in therapy of severe COVID-19. Biomedicine & Pharmacotherapy, 2020: p. 110698.
24. Chen, H.-W., et al., Nasal commensal Staphylococcus epidermidis counteracts influenza virus. Scientific reports, 2016. 6: p. 27870.
25. Kim, H.J., et al., Nasal commensal Staphylococcus epidermidis enhances interferon-λ-dependent immunity against influenza virus. Microbiome, 2019. 7(1): p. 1-12.
26. Keshari, S., et al., Butyric acid from probiotic staphylococcus epidermidis in the skin microbiome down-regulates the ultraviolet-induced pro-inflammatory IL-6 cytokine via short-chain fatty acid receptor. International journal of molecular sciences, 2019. 20(18): p. 4477.
27. Traisaeng, S., et al., A derivative of butyric acid, the fermentation metabolite of Staphylococcus epidermidis, inhibits the growth of a Staphylococcus aureus strain isolated from atopic dermatitis patients. Toxins, 2019. 11(6): p. 311.
28. Balasubramaniam, A., et al., Skin bacteria mediate glycerol fermentation to produce electricity and resist UV-B. Microorganisms, 2020. 8(7): p. 1092.
29. Sacco, N.J., M.C. Bonetto, and E. Cortón, Isolation and characterization of a novel electrogenic bacterium, Dietzia sp. RNV-4. PLoS one, 2017. 12(2): p. e0169955.
30. Kao, M.S., et al., Microbiome precision editing: Using PEG as a selective fermentation initiator against methicillin‐resistant Staphylococcus aureus. Biotechnology journal, 2017. 12(4).
31. Antunes, M.B., et al., Murine nasal septa for respiratory epithelial air-liquid interface cultures. Biotechniques, 2007. 43(2): p. 195-204.
32. Wang, W., et al., Up-regulation of IL-6 and TNF-α induced by SARS-coronavirus spike protein in murine macrophages via NF-κB pathway. Virus research, 2007. 128(1-2): p. 1-8.
33. Light, S.H., et al., A flavin-based extracellular electron transfer mechanism in diverse Gram-positive bacteria. Nature, 2018. 562(7725): p. 140-144.
34. Sebastián, M., et al., The Biosynthesis of Flavin Cofactors in Listeria monocytogenes. Journal of molecular biology, 2019. 431(15): p. 2762-2776.
35. Mansjö, M. and J. Johansson, The Riboflavin analog Roseoflavin targets an FMN-riboswitch and blocks Listeria monocytogene s growth, but also stimulates virulence gene-expression and infection. RNA biology, 2011. 8(4): p. 674-680.
36. Miroux, B. and J.E. Walker, Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. Journal of molecular biology, 1996. 260(3): p. 289-298.
37. Patil, S.A., C. Hägerhäll, and L. Gorton, Electron transfer mechanisms between microorganisms and electrodes in bioelectrochemical systems. Bioanalytical reviews, 2012. 4(2-4): p. 159-192.
38. Sarjit, A., S.M. Tan, and G.A. Dykes, Surface modification of materials to encourage beneficial biofilm formation. AIMS Bioeng, 2015. 2(4): p. 404-422.
39. Finke, N., V. Vandieken, and B.B. Jørgensen, Acetate, lactate, propionate, and isobutyrate as electron donors for iron and sulfate reduction in Arctic marine sediments, Svalbard. FEMS Microbiology Ecology, 2007. 59(1): p. 10-22.
40. Keshari, S., et al., Skin cutibacterium acnes mediates fermentation to suppress the calcium phosphate-induced itching: A butyric acid derivative with potential for uremic pruritus. Journal of clinical medicine, 2020. 9(2): p. 312.
41. Wang, G., et al., The G protein-coupled receptor FFAR2 promotes internalization during influenza A virus entry. Journal of Virology, 2020. 94(2).
42. Del Pozo, J.S.-G., et al., A systematic review on the efficacy and safety of IL-6 modulatory drugs in the treatment of COVID-19 patients. European review for medical and pharmacological sciences, 2020. 24(13): p. 7475-7484.
43. Fiume, M.M., et al., Safety Assessment of alkyl esters as used in cosmetics. International journal of toxicology, 2015. 34(2_suppl): p. 5S-69S.
44. Huang, W.-C., et al., Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid. Journal of dermatological science, 2014. 73(3): p. 232-240.
45. Zhang, X., et al., Caprylic acid suppresses inflammation via TLR4/NF-κB signaling and improves atherosclerosis in ApoE-deficient mice. Nutrition & metabolism, 2019. 16(1): p. 1-16.
46. Liu, J., et al., Sodium butyrate inhibits the inflammation of lipopolysaccharide-induced acute lung injury in mice by regulating the toll-like receptor 4/nuclear factor κB signaling pathway. Journal of agricultural and food chemistry, 2019. 67(6): p. 1674-1682.
47. Namour, F., et al., Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects. British journal of clinical pharmacology, 2016. 82(1): p. 139-148.
48. Huang, W., et al., Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling. Oxidative Medicine and Cellular Longevity, 2020. 2020.
49. Marsili, E., et al., Shewanella secretes flavins that mediate extracellular electron transfer. Proceedings of the National Academy of Sciences, 2008. 105(10): p. 3968-3973.
50. Lee, E.R., K.F. Blount, and R.R. Breaker, Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA biology, 2009. 6(2): p. 187-194.
51. Luo, Q., et al., Effect of direct electric current on the cell surface properties of phenol-degrading bacteria. Applied and environmental microbiology, 2005. 71(1): p. 423-427.
52. van der Stel, A.X., et al., Generation of the membrane potential and its impact on the motility, ATP production and growth in Campylobacter jejuni. Molecular Microbiology, 2017. 105(4): p. 637-651.
53. MacLea, K.S. and A.M. Trachtenberg, Complete genome sequence of Staphylococcus epidermidis ATCC 12228 chromosome and plasmids, generated by long-read sequencing. Genome Announcements, 2017. 5(36).
54. Cao, X., COVID-19: immunopathology and its implications for therapy. Nature reviews immunology, 2020. 20(5): p. 269-270.
55. Channappanavar, R. and S. Perlman. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. in Seminars in immunopathology. 2017. Springer. |